Dr. DuVall will serve as Co-Director of the Adolescent and Young Adult (AYA) Program at Huntsman Cancer Institute alongside Douglas Fair, MD. In this role, he will care for adolescents and young adults with hematologic malignancies, including patients requiring cellular therapies and stem cell transplantation.

Dr. DuVall earned both his Doctor of Medicine and Master of Public Health degrees from Case Western Reserve University. He completed a combined residency in internal medicine and pediatrics at the University of Michigan, followed by a medical oncology fellowship at Oregon Health & Science University and a pediatric hematology/oncology fellowship at Doernbecher Children's Hospital. He is one of fewer than 10 physicians in the United States to complete formal fellowship training in both adult and pediatric oncology, bringing a rare breadth of expertise to the care of adolescent and young adult patients.

His clinical practice focuses on the diagnosis and treatment of cancer in adolescents and young adults, with particular expertise in acute leukemias and aggressive lymphomas. He is also deeply committed to addressing the unique psychosocial needs of AYA patients throughout their cancer journey. Dr. DuVall recently authored the adolescent and young adult clinical guidelines for acute lymphoblastic leukemia, underscoring his national leadership in the field. Most recently, he served on the Adolescent and Young Adult Oncology Program at the University of Chicago Medicine, where he provided comprehensive, multidisciplinary care for this unique patient population.

Dr. DuVall's research is centered on translating promising therapies for leukemia and lymphoma into clinical practice while ensuring that patient perspectives remain central to treatment development. His work incorporates patient-reported outcomes and health-related quality-of-life measures into prospective clinical trials, helping to elevate the patient voice in cancer research. He also studies strategies to reduce the long-term psychosocial impact of cancer and its treatment on adolescents and young adults, with the goal of developing interventions that improve survivorship and overall quality of life.

Dr. DuVall's arrival marks an exciting step forward for the Huntsman Cancer Institute AYA Program. His unique combination of adult and pediatric oncology expertise, commitment to multidisciplinary care, and innovative research will strengthen our ability to meet the complex needs of adolescent and young adult patients with hematologic malignancies.

Please join us in welcoming Dr. DuVall to the Division of Hematology and Hematologic Malignancies.